Knowledge Ecology International (KEI) is an accredited non-state actor at the World Health Organization (WHO). This is our statement at the WHO Executive Board Special Session on the COVID-19 response. https://extranet.who.int/nonstateactorsstatements/print/book/export/html/3916?destination=node/3916 Knowledge Ecology International Meeting: EB Special session on the… Continue Reading →
Senator Durbin has written letters to vaccine manufacturers Moderna, AstraZeneca, Sanofi, GlaxoSmithKline, Merck, Pfizer, Novavax, and Janssen/Johnson & Johnson, asking eight detailed questions. Question 8 asked about federal funding of the vaccine, government rights in patents, and the by Bayh-Dole… Continue Reading →
On Friday, 10 July 2020, the European Parliament adopted a resolution entitled, The EU’s public health strategy post-COVID-19, by 526 votes to 105 and 50 abstentions. This resolution paves the way for the creation of a European Health Union and… Continue Reading →
On 14 May 2020, Bernd Lange, Chair of the European Parliament’s Committee on International Trade (INTA) wrote a letter to Phil Hogan (Commissioner for Trade, European Commission) on the “commercial aspects of intellectual property rights for medical products in the… Continue Reading →
UPDATE: The World Health Organization has published the COVID-19 response resolution as a conference paper (A73/CONF./1) marked with the date of 18 May 2020. The sponsors of the draft resolution included: Albania, Australia, Bahrain, Bangladesh, Belarus, Bhutan, Bolivia (Plurinational State… Continue Reading →
On April 29, 2020, the United States Trade Representative (USTR) published its annual Special 301 Report. A PDF copy of the report is available here. KEI has compiled copies of the Special 301 Report for every year since its inception… Continue Reading →
On Friday, 24 April 2020, Knowledge Ecology International submitted comments on the resolution WHA73: “Covid-19 Response” proposed by the European Union (EU). The original zero draft text and the note verbale proposed by the European Union can be found here.… Continue Reading →
Brazil-CL-Pandemics-KEI-10April2020 April 10, 2020 Members of the Brazil Congress It is our understanding that some large drug companies have raised objections to a new compulsory licensing authority for Brazil relating to pandemics. I would like to address the several objections… Continue Reading →
COVID-19 Gov’t Contracts: KEI has obtained numerous contracts between the federal government and pharmaceutical companies regarding COVID-19 medical technologies via the Freedom of Information act. For these and other contracts, please see: https://www.keionline.org/covid-contracts. COVID-19 Vaccine Manufacturing: KEI has gathered data… Continue Reading →
Updated between 11 March 2020 to 18 March 2020 to include reactions from stakeholders on the nomination of Daren Tang (Singapore) as Director General of the World Intellectual Property Organization (WIPO) Brook K. Baker, Senior Policy Analyst Health GAP (Global… Continue Reading →
